Aytu - M&A Summary and Business Overview

Life ScienceCompany

Aytu M&A Summary

Aytu has acquired 3 companies, including 1 in the last 5 years.

Aytu’s largest acquisition to date was in 2019, when it acquired Innovus Pharmaceuticals for $8M. Aytu has acquired in 2 different US states. The Company’s most targeted sectors include medical products (67%) and life science (34%).

Aytu Business Overview

Where is Aytu headquartered?

Aytu is headquartered in Englewood, Colorado.

What is Aytu’s revenue?

Aytu disclosed revenue of 97M USD for 2022 and 66M USD for 2021.

How many employees does Aytu have?

Aytu has 164 employees.

What sector is Aytu in?

Aytu is a life science company.

When was Aytu founded?

Aytu was founded in 2015.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Aytu

Aytu BioScience, Inc.

3373 Inverness Parkway Suite 206,
Englewood, Colorado 80112
United States,
(720) 437-6580
www.aytubio.com

Aytu is a specialty healthcare company concentrating on developing products for redox-modulated conditions with a focus on urological indications and related conditions. Aytu Biopharma was founded in 2015 and is based in Englewood, Colorado.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $8M $8M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Innovus Pharmaceuticals, Inc. 2019-09-12 8M USD Add-on Acquisition
San Diego, California · www.innovuspharma.com
Nuelle, Inc. (Fiera) 2017-05-09 - Add-on Acquisition
Mountain View, California · www.fiera.com
Jazz Pharmaceuticals - Prostate Cancer Biologic 2015-06-09 - Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 2 (67%) 8M (100%) - -
Life Science 1 (33%) - - -
Total 3 $8M - -

By Geo

State/Country Buy Value Sell Value
United States 3 8M - -
  California 2 8M - -
Total 3 $8M - -

Deal Values

buy # Total
< $100M 1 $8M
TOTAL $8M
Largest Innovus Pharmaceuticals, Inc.
$8M (2019-09-12)

M&A Connections

Deals
Acquired from
Strategic(s)
33%
1 (33%)

 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.